Tivozanib for patients with metastatic renal cell carcinoma: a critical review of the evidence and its dissemination into the scientific literature - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Fundamental & Clinical Pharmacology Année : 2021
Fichier non déposé

Dates et versions

hal-03329938 , version 1 (31-08-2021)

Identifiants

  • HAL Id : hal-03329938 , version 1

Citer

L. Caquelin, B. Laviolle, Florian Naudet, C. Locher. Tivozanib for patients with metastatic renal cell carcinoma: a critical review of the evidence and its dissemination into the scientific literature. Fundamental & Clinical Pharmacology, 2021, 35 (SI), pp.53-53. ⟨hal-03329938⟩
31 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More